J P Morgan Chase & Co Reaffirms “Buy” Rating for Bayer AG (BAYN)
Bayer AG (FRA:BAYN)‘s stock had its “buy” rating reissued by equities researchers at J P Morgan Chase & Co in a note issued to investors on Wednesday.
Several other research analysts have also recently issued reports on the stock. Goldman Sachs Group, Inc. (The) set a €125.00 ($148.81) target price on shares of Bayer AG and gave the company a “buy” rating in a report on Monday, July 24th. Deutsche Bank AG set a €124.00 ($147.62) target price on shares of Bayer AG and gave the company a “buy” rating in a report on Monday, July 10th. Citigroup Inc. restated a “buy” rating on shares of Bayer AG in a report on Wednesday, July 5th. Commerzbank Ag set a €126.00 ($150.00) target price on shares of Bayer AG and gave the company a “buy” rating in a report on Wednesday, June 7th. Finally, Sanford C. Bernstein set a €128.00 ($152.38) target price on shares of Bayer AG and gave the company a “buy” rating in a report on Monday, May 22nd. Nine analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus target price of €119.55 ($142.32).
Shares of Bayer AG (BAYN) opened at 110.775 on Wednesday. The firm has a market capitalization of €96.61 billion and a P/E ratio of 19.162. The stock’s 50 day moving average is €108.00 and its 200 day moving average is €111.16. Bayer AG has a 1-year low of €85.72 and a 1-year high of €123.83.
COPYRIGHT VIOLATION WARNING: This news story was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this news story on another website, it was illegally stolen and republished in violation of United States & international trademark and copyright law. The legal version of this news story can be viewed at https://www.thecerbatgem.com/2017/09/13/j-p-morgan-chase-co-reaffirms-buy-rating-for-bayer-ag-bayn.html.
Bayer AG Company Profile
Receive News & Stock Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related stocks with our FREE daily email newsletter.